We set up Ranbaxy Malaysia as a wholly owned subsidiary in August 1982. With an excellent sales and marketing team, we are recognised as a leading pharmaceutical manufacturer and enjoy significant brand recognition amongst general practitioners, private and Government hospitals and in the retail pharmacy sector.
At a Glance
Launched Operations: 1982
No. of Molecules: 82
Leading Molecules: Atorvastatin Calcium, Levofloxacin, Amlodipine Besilate, Amoxicillin+Clavulanic Acid, Ranitidine, Clarithromycin, Oseltamivir, Omeprazole, Fexofenadine + Pseudoephedrine, Diclofenac, Sertraline, Zolpidem, Metformin OD, Clarithromycin+Omeprazole+Tinidazole, Clopidogrel, Gliclazide, Simvastatin, Cefaclor
Presence in Therapeutic Segments: Anti-infectives, Anti-depressants, Anti-ulcerants, Anti-histamines, Analgesics, Tranquillizers, Diabetes, Lipid Lowering Agents, Anti-hypertensives, Over-the-Counter (OTC)
Area Director-ASEAN & Sri Lanka,
RANBAXY (MALAYSIA) SDN. BHD.
Peti #8, 5th Floor, South Block,
Wisma Selangor Dredging,
142-A, Jalan Ampang,
50450 Kuala Lumpur,
|+603 -216 141 81|
|+603 -216 275 93|
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement.
The products listed in this page are meant only of the specific country(ies) mentioned in this page and not for any other market or country.